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a  b  s  t  r  a  c  t
Rheumatoid arthritis (RA) is a chronic systemic inﬂammatory autoimmune disease and
its  main manifestation is persistent synovitis affecting peripheral joints symmetrically, In
spite of its destructive potential, the evolution of RA is highly variable. Some patients may
have only a short-term process oligoarticular with minimum lesion, while others suffer a
polyarthritis evolving with progressive and continuous involvement of other organ systems
such  as skin, heart, lungs, muscles and blood vessels rarely leading to rheumatoid vasculitis.
The  aim of this study was to describe a case of rheumatoid vasculitis a rare and severe
condition.
©  2014 Elsevier Editora Ltda. All rights reserved.
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Vasculite reumatoide
r  e  s  u  m  o
A artrite reumatoide (AR) é uma doenc¸a crônica autoimune inﬂamatória sistêmica e sua
principal manifestac¸ão é a sinovite persistente, que compromete articulac¸ões periféricas
de  forma simétrica. Apesar do seu potencial destrutivo, a evoluc¸ão da AR é muito variável.
Alguns pacientes podem ter apenas um processo de curta durac¸ão oligoarticular com lesão
mínima, enquanto outros sofrem uma poliartrite progressiva e contínua e evoluem comacometimento de outros órgãos e sistemas, como pele, corac¸ão, pulmões, músculos e mais
raramente vasos sanguíneos, que leva à vasculite reumatoide. O objetivo deste estudo foi
descrever um caso de vasculite reumatoide, uma condic¸ão rara e grave.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.
 Work conducted at Santa Casa da Misericórdia do Rio de Janeiro – P
∗ Corresponding author.
E-mail addresses: inahpecly@terra.com.br, ipecly@yahoo.com (I.M.D
http://dx.doi.org/10.1016/j.rbre.2014.07.006
2255-5021/© 2014 Elsevier Editora Ltda. All rights reserved.rofessor Milton dos Reis Arantes 4th and 20th wards Service.
. Pecly).
 . 2 0 1 5;5 5(6):528–530 529
I
S
a
T
r
c
o
t
v
C
6
o
i
a
s
a
e
l
r
t
i
l
u
t
e
i
ﬁ
t
j
a
a
l
F
w
a
r
Fig. 2 – Vasculitis in lower limbs. Shallow-edged ulcerated
vasculitic lesions with moderate serosanguineous secretion
in the distal two-thirds of the lower limbs, secondary tor e v b r a s r e u m a t o l
ntroduction
ystemic vasculitis has been a diagnostic challenge in the
reas of clinical medicine and rheumatology for many  years.
he rheumatoid vasculitis, rare and severe complication of
heumatoid arthritis, is one of them. The most common
utaneous presentation of rheumatoid vasculitis is the devel-
pment of palpable purpura in the lower extremities that if not
reated early enough can evolve into a multi-organ systemic
asculitis.1
ase  report
4-year old, non-Caucasian, female patient, with RA, with-
ut treatment for 25 years. Six years ago, developed edema
n her left lower limb, erythema and hard lumps that ulcer-
ted in the lateral leg region with moderate serosanguineous
ecretion. She was treated with multiple topical and systemic
ntibiotics, but showed no improvement. The size of the lesion
volved until it involved the distal two-thirds of the left lower
imb. Two years later, she presented similar ulceration in the
ight leg, for which she received several topical, unspeciﬁc
reatments, but did not obtain a good response. Due to the
mpairment of her general condition and worsening of the
esions, she sought a health care unit, where she was eval-
ated and referred for hospital treatment. Upon admission to
he hospital, the patient was in regular general condition –
maciated, presenting asthenia and anemia, claiming morn-
ng stiffness for over an hour, showing ulnar deviation of the
ngers in symmetrical hands with bony prominences both in
he metacarpophalangeal and the proximal interphalangeal
oints (Fig. 1), impairment of bilateral elbows and knees. She
lso presented shallow-edged ulcerated lesions with moder-
te serosanguineous secretion in the distal two-thirds of her
ower limbs (Fig. 2).
ig. 1 – Hand deformities. Ulnar deviation of the ﬁngers
ith bony prominences both in the metacarpophalangeal
nd the proximal interphalangeal joints, secondary to
heumatoid arthritis.rheumatoid arthritis.
She was diagnosed with seropositive RA according to the
criteria of the 1987 American College of Rheumatology, pre-
senting over four criteria (morning stiffness, arthritis of 3 or
more  joint areas, arthritis of hand joints, symmetric arthritis
and positive rheumatoid factor) and scoring greater than 6 in
the new classiﬁcation criteria for rheumatoid arthritis, 2010
ACR/EULAR (joint involvement score 5, serology score 3, dura-
tion of symptoms score 1), DAS disease activity score28: 4.83
(moderate activity), complicated by rheumatoid vasculitis.
The diagnostic was made according to clinical evaluation of
the rheumatology service. She was treated with methotrexate
15 mg/week after systemic antibiotics and topical treatment
of the ulcers, showing signiﬁcant improvement of the lesions
in the lower limbs and of her general condition. She was
discharged from hospital to continue the treatment as out-
patient.
Laboratory  tests
CBC: RBC 3.81 million/mL, hemoglobin 7.8 g; hematocrit
24.6%; mean corpuscular volume 64.6 fL; mean corpuscular
hemoglobin 20.5 pg; mean corpuscular hemoglobin con-
centration 31.7 g/dL; anisocytosis index 20.4%; leukocytes
2950; segmented 44%; lymphocytes 39%; monocytes 8%;
platelets 404 thousand. Hematoscopy: microcytic erythro-
cytes; intense hypochromia; numerous red blood cells in
target and rare elliptocytes; presence of Rouleaux; serum iron
29 mcg/dL (reference 60–160 mcg/dL); transferrin saturation
index 18.13% (reference 20–25%); erythrocyte sedimentation
rate 35 mm;  creatinine 0.5 mg/dL; urea 15 mg/dL; rheuma-
toid factor 94 UI/mL (reference: until 20 UI/mL, turbidimetry,
repeated and conﬁrmed); non-reactive anti HIV 1–2 antibod-
ies; anti HBs, reagent (193.6 mUI/mL). Reference: non-reagent
less than 10 mUI/mL; non-reagent HbsAg; non-reagent anti-
HCV. Total abdominal ultrasonography: without alterations,
with normal spleen volume and homogeneous texture.
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Discussion
Rheumatoid arthritis (RA) is a relatively common chronic
inﬂammatory autoimmune disease that affects men  and
women of all ages, with worldwide presence. It affects 0.3–2.1%
of the world population, but in some, such as the black pop-
ulation in the Caribbean and rural population in Sub-Saharan
Africa, the disease is less recurrent and less severe.2 In Brazil,
it is estimated that around 1.3 million people are affected,
being more  common in the age group between 30 and 50 years
old, mostly women than man, in a proportion of 3:1.3 Its clin-
ical presentation is characterized by the joint involvement, in
an insidious process that often results in deformities. How-
ever, it is important to acknowledge that RA is a systemic
disease. Because of that, in addition to joint manifestations,
several organs and speciﬁc systems can be affected, enabling
the onset of various extra-articular manifestations.4 These
manifestations are usually observed in individuals with high
titers of rheumatoid factor and anti-CCP.5 Our patient pre-
sented rheumatoid factor of 94 UI/mL (reference limit up to
20 UI/mL), three times greater than the upper limit of normal.
Rheumatoid vasculitis is a form of cutaneous presenta-
tion with annual incidence of 12.5/1 million that typically
affects small and medium-sized vessels, with associated
peripheral neuropathy (often motor), digital gangrene, nail
bed infarcts and palpable purpura.6 The spectrum of clin-
ical lesions reported in the rheumatoid vasculitis is broad
and varies with the size and the location of the affected ves-
sels and the extent of the disease.7 This is a rare and severe
complication that must be diagnosed early enough, given the
large interference in the evolution, treatment and prognosis
of the underlying disease. Our patient did not undergo an
anatomopathological examination (biopsy) as it is not eas-
ily accessible in the institution. The diagnosis was based on
the clinical presentation and the experience of the Hospital’s
rheumatology service.
Due to the presence of neutropenia, we investigated the
possibility of Felty’s syndrome (rheumatoid arthritis, neu-
tropenia and splenomegaly). However, the patient did not
show signs of splenomegaly in the physical examination or
in the abdominal ultrasound, removing this hypothesis.
The patient presented microcytic, hypochromic anemia
with low iron levels and high RDW, low transferrin satura-
tion index compatible with iron-deﬁciency anemia, associated
to low ingestion of speciﬁc foods, according to dietary recall,
associated to anemia of chronic disease. 0 1 5;5 5(6):528–530
One of the aspects that make this case particularly interest-
ing is the fact that this disease evolved for many  years without
any kind of treatment for the underlying disease (rheumatoid
arthritis) or the vasculitis, which highlights the importance of
proper diagnosis and early treatment of the disease.
Conclusion
Despite being a rare condition, it is important to be aware
of the development of rheumatoid vasculitis in the clinical
course of rheumatoid arthritis so the appropriate treatment
can be promptly instituted, thus avoiding the progression of
lesions and possible associated complications.
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